SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AXYS Pharmaceuticals Inc.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LLCF who wrote (260)5/12/1999 2:23:00 PM
From: David Bogdanoff  Read Replies (1) of 455
 
DAK;

I have followed this thread for a couple of years. Generally, comments on management have been favorable. My impression from an annual shareholders meeting that I attended is the same. Actually, you can pretty well tell from the scope of operations alot about their management and their technology. Many big collaborations is a sign of good management, or at least a management that can impress other pharma companies. The stock took a big hit on a acquisition some months ago and has never recovered. Oddly, there are commentators on the biotech sector who feel that M&As are really important for progress, and the reason why more don't happen is something called ego.

David
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News